RetractedArticleCancer cell international2019

LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway.

Jie Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.